What happened, in summary

Megan was 33, active, a never-smoker, and raising 2 young children when chest pain began. Urgent care and ER visits first led to explanations such as a pulled muscle or anxiety. Then she developed shortness of breath on walks, arm pain, and visible veins in her arm. An ER visit found extensive blood clots in her arms, a pulmonary embolism, a lung tumor, cancer in her spine, and disease in chest and stomach lymph nodes. A mediastinoscopy removed a lymph node for testing. It showed carcinoma, and about 2 weeks later she learned it was Stage IV non-small cell lung cancer. Chemotherapy was discussed at first, but biomarker testing changed the path. Megan’s cancer was ALK-positive, which meant she could start a daily targeted therapy pill instead of traditional chemotherapy. She began at a lower dose and expected to stay on the pills indefinitely. The response was fast: within 10 days, she went from being couch-ridden and unable to read a children’s book without coughing to playing with her daughters again. Her first scans about 1.5 months later showed a 40% reduction in cancer, and later scans showed more than 50% gone. As of March 2026, Megan’s latest scans were described as no evidence of disease while she continued ALK-targeted therapy.